These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 29234213)

  • 1. Progress in Nanomedicine: Approved and Investigational Nanodrugs.
    Ventola CL
    P T; 2017 Dec; 42(12):742-755. PubMed ID: 29234213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patented and Approval Scenario of Nanopharmaceuticals with Relevancy to Biomedical Application, Manufacturing Procedure and Safety Aspects.
    Agarwal V; Bajpai M; Sharma A
    Recent Pat Drug Deliv Formul; 2018; 12(1):40-52. PubMed ID: 29303083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanodrugs used in cancer therapy.
    Kopeckova K; Eckschlager T; Sirc J; Hobzova R; Plch J; Hrabeta J; Michalek J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Jun; 163(2):122-131. PubMed ID: 30967685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanopharmaceuticals (part 2): products in the pipeline.
    Weissig V; Guzman-Villanueva D
    Int J Nanomedicine; 2015; 10():1245-57. PubMed ID: 25709446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Where Are the Nanodrugs? An Industry Perspective on Development of Drug Products Containing Nanomaterials.
    Havel HA
    AAPS J; 2016 Nov; 18(6):1351-1353. PubMed ID: 27520380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine and epigenome. Possible health risks.
    Smolkova B; Dusinska M; Gabelova A
    Food Chem Toxicol; 2017 Nov; 109(Pt 1):780-796. PubMed ID: 28705729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine: de novo design of nanodrugs.
    Yang Z; Kang SG; Zhou R
    Nanoscale; 2014 Jan; 6(2):663-77. PubMed ID: 24305636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
    Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials.
    Caster JM; Patel AN; Zhang T; Wang A
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jan; 9(1):. PubMed ID: 27312983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine: a pharma perspective.
    Brown PD; Patel PR
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(2):125-30. PubMed ID: 25196070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Toxicological Considerations of Nanomedicines: The Future Directions.
    Patel P; Shah J
    Curr Clin Pharmacol; 2017; 12(2):73-82. PubMed ID: 28486906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle therapeutics: a personal perspective.
    McNeil SE
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):264-71. PubMed ID: 20049796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation aspects of nanopharmaceuticals and nanotechnology I Introduction, biopharmaceutical aspects.
    Viktor F; Emese B; Geza J; Istvan A
    Acta Pharm Hung; 2016; 86(2):43-52. PubMed ID: 29873962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology: Revolutionizing the Science of Drug Delivery.
    Mishra M; Kumar P; Rajawat JS; Malik R; Sharma G; Modgil A
    Curr Pharm Des; 2018; 24(43):5086-5107. PubMed ID: 30727873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted nanodrugs for cancer therapy: prospects and challenges.
    Bottini M; Sacchetti C; Pietroiusti A; Bellucci S; Magrini A; Rosato N; Bottini N
    J Nanosci Nanotechnol; 2014 Jan; 14(1):98-114. PubMed ID: 24730253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date.
    Bobo D; Robinson KJ; Islam J; Thurecht KJ; Corrie SR
    Pharm Res; 2016 Oct; 33(10):2373-87. PubMed ID: 27299311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards improved therapies using nanopharmaceuticals: recent patents on pharmaceutical nanoformulations.
    Horstkotte E; Odoerfer KI
    Recent Pat Food Nutr Agric; 2012 Dec; 4(3):220-44. PubMed ID: 23013408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Advances in Nanopharmaceuticals.
    Öztürk-Atar K; Eroğlu H; Gürsoy RN; Çaliş S
    J Nanosci Nanotechnol; 2019 Jul; 19(7):3686-3705. PubMed ID: 30764926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanopharmaceuticals: Tiny challenges for the environmental risk assessment of pharmaceuticals.
    Berkner S; Schwirn K; Voelker D
    Environ Toxicol Chem; 2016 Apr; 35(4):780-7. PubMed ID: 25931425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.